Skip to main content
Erschienen in:
Buchtitelbild

2014 | OriginalPaper | Buchkapitel

1. Engineering in Translational Medicine: An Introduction

verfasst von : Weibo Cai

Erschienen in: Engineering in Translational Medicine

Verlag: Springer London

Aktivieren Sie unsere intelligente Suche, um passende Fachinhalte oder Patente zu finden.

search-config
loading …

Abstract

Molecular and personalized medicine is the future for patient management. Translational medicine, a continuum of research that spans from basic science to clinical applications, is the key to twenty-first century personalized medicine. Engineering is an indispensable component of translational medicine. This book will cover a broad spectrum of engineering research in translational medicine, where leaders in each research topic provide a state-of-the-art summary in 34 chapters on various topics such as cell and tissue engineering (6 chapters), genetic and protein engineering (10 chapters), nanoengineering (10 chapters), biomedical instrumentation (4 chapters), and theranostics and other novel approaches (4 chapters). This book will give the readers a comprehensive and in-depth overview of a broad array of research areas, which can serve as an invaluable reference book for scientists/students/clinicians both new to engineering and currently working in this area.

Sie haben noch keine Lizenz? Dann Informieren Sie sich jetzt über unsere Produkte:

Springer Professional "Wirtschaft+Technik"

Online-Abonnement

Mit Springer Professional "Wirtschaft+Technik" erhalten Sie Zugriff auf:

  • über 102.000 Bücher
  • über 537 Zeitschriften

aus folgenden Fachgebieten:

  • Automobil + Motoren
  • Bauwesen + Immobilien
  • Business IT + Informatik
  • Elektrotechnik + Elektronik
  • Energie + Nachhaltigkeit
  • Finance + Banking
  • Management + Führung
  • Marketing + Vertrieb
  • Maschinenbau + Werkstoffe
  • Versicherung + Risiko

Jetzt Wissensvorsprung sichern!

Springer Professional "Technik"

Online-Abonnement

Mit Springer Professional "Technik" erhalten Sie Zugriff auf:

  • über 67.000 Bücher
  • über 390 Zeitschriften

aus folgenden Fachgebieten:

  • Automobil + Motoren
  • Bauwesen + Immobilien
  • Business IT + Informatik
  • Elektrotechnik + Elektronik
  • Energie + Nachhaltigkeit
  • Maschinenbau + Werkstoffe




 

Jetzt Wissensvorsprung sichern!

Literatur
1.
Zurück zum Zitat DiMasi JA, Hansen RW, Grabowski HG (2003) The price of innovation: new estimates of drug development costs. J Health Econ 22(2):151–185CrossRef DiMasi JA, Hansen RW, Grabowski HG (2003) The price of innovation: new estimates of drug development costs. J Health Econ 22(2):151–185CrossRef
4.
Zurück zum Zitat Contag CH, Bachmann MH (2002) Advances in in vivo bioluminescence imaging of gene expression. Annu Rev Biomed Eng 4:235–260CrossRef Contag CH, Bachmann MH (2002) Advances in in vivo bioluminescence imaging of gene expression. Annu Rev Biomed Eng 4:235–260CrossRef
7.
Zurück zum Zitat Pfleger KD, Eidne KA (2006) Illuminating insights into protein–protein interactions using bioluminescence resonance energy transfer (BRET). Nat Methods 3(3):165–174. doi:10.1038/nmeth841 CrossRef Pfleger KD, Eidne KA (2006) Illuminating insights into protein–protein interactions using bioluminescence resonance energy transfer (BRET). Nat Methods 3(3):165–174. doi:10.​1038/​nmeth841 CrossRef
10.
Zurück zum Zitat Mammen M, Chio S, Whitesides GM (1998) Polyvalent interactions in biological systems: implications for design and use of multivalent ligands and inhibitors. Angew Chem Int Ed Engl 37(20):2755–2794 Mammen M, Chio S, Whitesides GM (1998) Polyvalent interactions in biological systems: implications for design and use of multivalent ligands and inhibitors. Angew Chem Int Ed Engl 37(20):2755–2794
12.
Zurück zum Zitat Rice J, Ottensmeier CH, Stevenson FK (2008) DNA vaccines: precision tools for activating effective immunity against cancer. Nat Rev Cancer 8(2):108–120. doi:10.1038/nrc2326 CrossRef Rice J, Ottensmeier CH, Stevenson FK (2008) DNA vaccines: precision tools for activating effective immunity against cancer. Nat Rev Cancer 8(2):108–120. doi:10.​1038/​nrc2326 CrossRef
15.
Zurück zum Zitat Farrell D, Alper J, Ptak K, Panaro NJ, Grodzinski P, Barker AD (2010) Recent advances from the National Cancer Institute Alliance for Nanotechnology in Cancer. ACS Nano 4(2):589–594. doi:10.1021/nn100073g CrossRef Farrell D, Alper J, Ptak K, Panaro NJ, Grodzinski P, Barker AD (2010) Recent advances from the National Cancer Institute Alliance for Nanotechnology in Cancer. ACS Nano 4(2):589–594. doi:10.​1021/​nn100073g CrossRef
16.
Zurück zum Zitat Ferrari M (2005) Cancer nanotechnology: opportunities and challenges. Nat Rev Cancer 5(3):161–171CrossRef Ferrari M (2005) Cancer nanotechnology: opportunities and challenges. Nat Rev Cancer 5(3):161–171CrossRef
17.
Zurück zum Zitat Service RF (2005) Materials and biology nanotechnology takes aim at cancer. Science 310(5751):1132–1134CrossRef Service RF (2005) Materials and biology nanotechnology takes aim at cancer. Science 310(5751):1132–1134CrossRef
18.
Zurück zum Zitat Horton MA, Khan A (2006) Medical nanotechnology in the UK: a perspective from the London Centre for Nanotechnology. Nanomedicine 2(1):42–48 Horton MA, Khan A (2006) Medical nanotechnology in the UK: a perspective from the London Centre for Nanotechnology. Nanomedicine 2(1):42–48
19.
Zurück zum Zitat Ptak K, Farrell D, Panaro NJ, Grodzinski P, Barker AD (2010) The NCI Alliance for Nanotechnology in Cancer: achievement and path forward. Wiley Interdiscip Rev Nanomed Nanobiotechnol 2(5):450–460. doi:10.1002/wnan.98 CrossRef Ptak K, Farrell D, Panaro NJ, Grodzinski P, Barker AD (2010) The NCI Alliance for Nanotechnology in Cancer: achievement and path forward. Wiley Interdiscip Rev Nanomed Nanobiotechnol 2(5):450–460. doi:10.​1002/​wnan.​98 CrossRef
21.
Zurück zum Zitat Michalet X, Pinaud FF, Bentolila LA, Tsay JM, Doose S, Li JJ, Sundaresan G, Wu AM, Gambhir SS, Weiss S (2005) Quantum dots for live cells, in vivo imaging, and diagnostics. Science 307(5709):538–544CrossRef Michalet X, Pinaud FF, Bentolila LA, Tsay JM, Doose S, Li JJ, Sundaresan G, Wu AM, Gambhir SS, Weiss S (2005) Quantum dots for live cells, in vivo imaging, and diagnostics. Science 307(5709):538–544CrossRef
22.
Zurück zum Zitat Cai W, Hsu AR, Li ZB, Chen X (2007) Are quantum dots ready for in vivo imaging in human subjects? Nanoscale Res Lett 2:265–281CrossRef Cai W, Hsu AR, Li ZB, Chen X (2007) Are quantum dots ready for in vivo imaging in human subjects? Nanoscale Res Lett 2:265–281CrossRef
25.
33.
Zurück zum Zitat Gambhir SS, Czernin J, Schwimmer J, Silverman DH, Coleman RE, Phelps ME (2001) A tabulated summary of the FDG PET literature. J Nucl Med 42(5):1S–93S Gambhir SS, Czernin J, Schwimmer J, Silverman DH, Coleman RE, Phelps ME (2001) A tabulated summary of the FDG PET literature. J Nucl Med 42(5):1S–93S
34.
Zurück zum Zitat Alauddin MM (2012) Positron emission tomography (PET) imaging with 18F-based radiotracers. Am J Nucl Med Mol Imaging 2(1):55–76 Alauddin MM (2012) Positron emission tomography (PET) imaging with 18F-based radiotracers. Am J Nucl Med Mol Imaging 2(1):55–76
38.
Zurück zum Zitat Chen XS (2011) Introducing theranostics journal-from the editor-in-chief. Theranostics 1:1–2CrossRef Chen XS (2011) Introducing theranostics journal-from the editor-in-chief. Theranostics 1:1–2CrossRef
39.
Zurück zum Zitat Becker H, Gartner C (2012) Microfluidics and the life sciences. Sci Prog 95(2):175–198CrossRef Becker H, Gartner C (2012) Microfluidics and the life sciences. Sci Prog 95(2):175–198CrossRef
Metadaten
Titel
Engineering in Translational Medicine: An Introduction
verfasst von
Weibo Cai
Copyright-Jahr
2014
Verlag
Springer London
DOI
https://doi.org/10.1007/978-1-4471-4372-7_1

Neuer Inhalt